Literature DB >> 3730413

N-acylethanolamine phospholipid metabolism in normal and ischemic rat brain.

V Natarajan, P C Schmid, H H Schmid.   

Abstract

N-Acylethanolamine phospholipids accumulate in rat brain during post-decapitative ischemia. Small amounts of these phospholipids consisting primarily of diacyl and alkenylacyl species can be detected within 15 min of ischemia and they increase linearly for 60 min. This ischemia-induced synthesis is more pronounced in developing rat brain (approx. 5.0 nmol/h per mumol lipid P) than in adult brain (0.4 nmol). Pulse labeling experiments with subcellular preparations of 10-day-old rat brain indicate a precursor-product relationship between ethanolamine phospholipids and their N-acyl analogs. N-Acylation of endogenous substrates occurs with both microsomes and mitochondria, exhibits a pH optimum of 10 and requires 1 mM Ca2+ for maximal (0.2 mM Ca2+ for half maximal) activity. Cell-free preparations of both developing and adult rat brain contain a phosphodiesterase which hydrolyzes N-acylphosphatidylethanolamine to phosphatidic acid and N-acylethanolamine. The latter is further hydrolyzed to fatty acid and ethanolamine by an amidohydrolase. [1-3H]Ethanolamine, injected intracerebrally or intraperitoneally into 13- and 18-day-old rats, is incorporated into brain ethanolamine phospholipids. Since small amounts of radioactivity are also associated with N-acylethanolamine phospholipids 5 and 24 h after injection of the substrate, it appears that these phospholipids may occur at a very low level as a natural lipid constituent of rat brain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3730413     DOI: 10.1016/0005-2760(86)90341-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  27 in total

1.  N-Myristoylated Phosphatidylethanolamine: Interfacial Behavior and Interaction with Cholesterol.

Authors:  Xin-Min Li; M Ramakrishnan; Howard L Brockman; Rhoderick E Brown; Musti J Swamy
Journal:  Langmuir       Date:  2002-01-08       Impact factor: 3.882

Review 2.  Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.

Authors:  Janos Paloczi; Zoltan V Varga; George Hasko; Pal Pacher
Journal:  Antioxid Redox Signal       Date:  2017-07-18       Impact factor: 8.401

Review 3.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD).

Authors:  Beatrice Castellani; Eleonora Diamanti; Daniela Pizzirani; Piero Tardia; Martina Maccesi; Natalia Realini; Paola Magotti; Gianpiero Garau; Thomas Bakkum; Silvia Rivara; Marco Mor; Daniele Piomelli
Journal:  Chem Commun (Camb)       Date:  2017-11-28       Impact factor: 6.222

5.  Aggregation and fusion of vesicles composed of N-palmitoyl derivatives of membrane phospholipids.

Authors:  M Mora; F Mir; M A de Madariaga; M L Sagristá
Journal:  Lipids       Date:  2000-05       Impact factor: 1.880

Review 6.  Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.

Authors:  Mario van der Stelt; Henrik H Hansen; Wouter B Veldhuis; Peter R Bär; Klaas Nicolay; Gerrit A Veldink; Johannes F G Vliegenthart; Harald S Hansen
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of stroke.

Authors:  P Garg; R S Duncan; S Kaja; P Koulen
Journal:  Neuroscience       Date:  2009-12-03       Impact factor: 3.590

8.  Influence of cerebral ischemia and post-ischemic reperfusion on mitochondrial oxidative phosphorylation.

Authors:  C K Kurup; K K Kumaroo; A J Dutka
Journal:  J Bioenerg Biomembr       Date:  1990-02       Impact factor: 2.945

9.  Elevated levels of nonesterified fatty acids in the myocardium of alloxan diabetic rats.

Authors:  J Chattopadhyay; E W Thompson; H H Schmid
Journal:  Lipids       Date:  1990-06       Impact factor: 1.880

Review 10.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.